Study of Parameters of Early Hepatitis C Virus Dynamics for Predicting the Outcome of Standard Interferon Therapy With Chinese Cohort
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Interferon alpha-2b; Ribavirin
- Indications Hepatitis C
- Focus Pharmacodynamics
- Acronyms sIFN-pred1
- 28 Oct 2011 Biomarkers information updated
- 27 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Sep 2011 New trial record